About the Cutaneous T Cell Lymphoma Session
Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin lymphoma, primarily affecting the skin. It arises from malignant T-cells, a type of white blood cell, leading to the formation of skin lesions. Research in CTCL focuses on understanding its pathogenesis, developing targeted therapies, and improving patient outcomes. Recent advancements include the identification of genetic mutations driving CTCL progression and the development of novel immunotherapies and targeted drugs such as monoclonal antibodies and immune checkpoint inhibitors. Additionally, studies exploring the tumor microenvironment and the role of immune cells in CTCL aim to uncover new treatment strategies. Collaborative efforts between researchers and clinicians continue to drive progress in unraveling the complexities of CTCL and devising more effective therapies for patients.
Topics Covered in Cutaneous T Cell Lymphoma
Mycosis Fungoides
Leukemic Variant
Clonality Testing
Skin-Directed Therapy
Electron Beam Therapy
HDAC Inhibitors
Related Scientific Sessions at CIOC 2027
Why Attend the Cutaneous T Cell Lymphoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cutaneous T Cell Lymphoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cutaneous T Cell Lymphoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cutaneous T Cell Lymphoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cutaneous T Cell Lymphoma Conference 2027 — FAQs
What is the Cutaneous T Cell Lymphoma track at CIOC 2027?
The Cutaneous T Cell Lymphoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cutaneous T Cell Lymphoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cutaneous T Cell Lymphoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Cutaneous T Cell Lymphoma are all welcome — whether presenting or attending.
Can I present my research in the Cutaneous T Cell Lymphoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cutaneous T Cell Lymphoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cutaneous T Cell Lymphoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.